
A | A lecturer in medicine has blamed Britain's exit from the European Union for a shortage of some medicines.,Dr. Bharat Pankhania, a senior clinical lecturer at The University of Exeter Medical School, told Sputnik that the recent shortage of hormone replacement therapy (HRT) and some other drugs — including insulin, antibiotics and antidepressants — was thanks to the UK leaving the bloc two years ago.,"There is a failure of authorities in the United Kingdom to what we call in English, address the elephant in the room," he said.,"Trade between the European Union and the United Kingdom is affected and it is affecting supplies of essential radio isotopes as well as antibiotics and cancer treatments," Pankhania said, "As well as other medicines. And this is a consequence of Brexit.",However, the Daily Express reported that the lack of HRT since April this year was caused by a shortage of material imported from the Far East.,The academic accused the government of having its head in the sand over the issue amid the leadership contest to replace Boris Johnson as prime minister.,"Ministers are in denial and do not want to address the big issue, which is our trade with the European Union, including pharmaceuticals, is affected," he reiterated. "They are pretending that it is not an issue. It is an issue and they are not addressing it.","What we really need is for the medical profession, for the pharmaceutical profession, for the other health care workers to have one voice and say it, loud and clear" Pankhania stressed.,WorldUK Pharmacists Warn Medicine Shortages Put Patients at Risk08:40 GMT,The senior medic warned that the problem could affect patients "across the board" in the National Health Service (NHS).,"They are across a range of ailments. They range from patients who need radio isotopes for cancer therapy," Pankhania said. "There are patients who need insulin for diabetes. And then there are patients who also need, for example, hormone replacement therapy".,A survey of 1,562 UK pharmacists for the Pharmaceutical Journal established that more than 54% of respondents said that patients had been put at risk in the last six months due to medicine shortages.,“We had to ration it, and this has potentially put patients at risk of vitamin deficiencies,” a pharmacist was cited as saying.,In response, a spokesperson for the UK Department of Health and Social Care insisted that they “take patient safety extremely seriously, and […] routinely share information about medicine supply issues directly with the NHS [National Health Service] so they can put plans in place to reduce the risk of any shortage impacting patients, including offering alternative medication.”。北京时间1月16日早些时候,路透社报道说,美国联邦巡回上诉法院周二在苹果和知识产权许可公司Virnetx的专利诉讼中维持了原判。Virnetx赢了官司,苹果输了官司。涉及的专利总额为4.4亿美元。法院驳回了苹果公司对2016年陪审团裁决的上诉,陪审团裁决价值3.02亿美元,现已上升至4.4亿美元,包括利息、增加的损害赔偿金和其他费用。同一专利诉讼已被行政法院裁定无效,但Virnetx正在上诉。

B | 苹果在一份声明中表示,对判决感到失望,并计划上诉。Virnetx没有立即回复置评请求。Virnetx总部位于内华达州的Zephyr Cove,由美国政府承包商Science Applications International Corporation的员工创建,拥有与安全网络和安全通信链接相关的专利。自2010年以来,Virnetx和苹果一直在为专利权诉讼而战,导致其股价大幅波动。

C |
Current article:http://zlhx1.zangjiwuqihuncongcherua.cyou/news/20260826_411897.html
Published on:13:46:56